Company intelligence / Profile preview

Aggredyne, Inc.

Houston, Texas, United Statesaggredyne.com ↗

Ownership: Private
Employees: ~4
Development stage: Commercial

Overview

Aggredyne has developed the A‑100 AggreGuide®, a diagnostic device for platelet function testing. Their patented products are CE marked and available in various international territories. The company continues to develop additional assays for use with its platform in the field of anti‑platelet therapy.[3]

Therapeutic areas: HematologyCardiovascular
Modalities: Diagnostic devices (platelet function monitoring)in vitro diagnostic assays
Industry: Protein Biomarker Diagnostics

Drug pipeline

2 assets

AggreGuide A-100

Commercial

Indications: Platelet function monitoring

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Aggredyne, Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aggredyne, Inc..

Explore the full profile